Guangxi Wuzhou Zhongheng Group, Ltd. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Guangxi Wuzhou Zhongheng Group, Ltd. with three other
companies in this sector in China:
Jiangzhong Pharmaceutical Company Limited
sales of 1.56 billion Chinese Renmimbi [US$226.64 million]
of which 100%
was Medical Industry),
Shanghai Shenqi Pharmaceutical Investment Management CoLtd
(1.60 billion Chinese Renmimbi [US$231.91 million]
of which 83%
was Pharmaceutical), and
Guangdong Zhongsheng Pharmaceutical Co Ltd
(1.69 billion Chinese Renmimbi [US$245.64 million]
of which 93%
was Medicine Manufacture).
During the year ended December of 2016, sales at
Guangxi Wuzhou Zhongheng Group, Ltd. were 1.67 billion Chinese Renmimbi (US$242.33 million).
increase of 24.5%
versus 2015, when the company's sales were 1.34 billion Chinese Renmimbi.
Despite this increase, sales are still
below the level achieved in 2014, when Guangxi Wuzhou Zhongheng Group, Ltd.
reported sales of 3.21 billion Chinese Renmimbi.
Sales of Pharmaceutical Segment saw an increase
27.5% in 2016, from
1.23 billion Chinese Renmimbi to 1.56 billion Chinese Renmimbi.
Not all segments of Guangxi Wuzhou Zhongheng Group, Ltd. experienced an increase in sales in 2016:
sales of Real Estate fell 76.8% to 5.61 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).